Lung Disease Clinical Trials

91 clinical trials for Lung Disease across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of the Disease Process of Lymphangioleiomyomatosis — RECRUITING
• Study of Lung Proteins in Patients With Pneumonia — RECRUITING
• Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC — RECRUITING · PHASE2
• TB Type and Spirometry Result vs. Functional Capacity Based on 6MWT in People With Post-TB Lung Disease — RECRUITING
• Point of Care Lung Ultrasound Examination in Patients With Shortness of Breath — RECRUITING · NA
• Cognitive Screening in Lung Cancer Patients — RECRUITING
• AN OPEN-LABEL EXTENSION STUDY OF INHALED TREPROSTINIL IN SUBJECTS WITH FIBROTIC LUNG DISEASE — RECRUITING
• REDUCING RESPIRATORY SYMPTOMS OF PULMONARY IRRADIATION IN INTERSTITIAL LUNG DISEASE (RESPIRE-ILD): A 2X2 FACTORIAL RANDOMIZED PHASE II TRIAL TESTING N-ACETYL CYSTEINE AND DEXAMETHASONE — RECRUITING · PHASE2
• PIONEERING PRE- AND POST-OPERATIVE INTEGRATIVE CARE TO IMPROVE THORACIC CANCER QUALITY OF CARE: THE THORACIC PERI-OPERATIVE INTEGRATIVE SURGICAL CARE EVALUATION (POISE) TRIAL - STAGE III — RECRUITING
• PULMONARY IMAGING REGISTRY (PIMREGISTRY) FOR INNOVATION IN RESPIRATORY MEDICINE — RECRUITING
• IMAGING MEASURES OF RESPIRATORY HEALTH REGISTRY (IMRH) — RECRUITING
• A PHASE 2B, MULTICENTER, RANDOMIZED, OPEN-LABEL, CONTROLLED, 3-ARM STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF SHP607 IN PREVENTING CHRONIC LUNG DISEASE THROUGH 12 MONTHS CORRECTED AGE COMPARED TO STANDARD NEONATAL CARE IN EXTREMELY PREMATURE INFANTS. — RECRUITING · PHASE2
• SINGLE-CENTRE STUDY EXPLORING THE UTILITY OF HYPERPOLARIZED 129XE MAGNETIC RESONANCE IMAGING IN HEALTHY VOLUNTEERS AND PATIENTS WITH LUNG DISEASE — RECRUITING
• Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP Facility — COMPLETED · NA
• A PHASE 1/2, OPEN-LABEL, MULTI-CENTER, DOSE ESCALATION, DOSE EXPANSION, AND SINGLE REPEAT DOSE STUDY OF TSRA-196 IN ADULTS WITH THE PIZZ GENOTYPE WHO HAVE LUNG AND/OR LIVER DISEASE ASSOCIATED WITH SEVERE ALPHA-1 ANTITRYPSIN DEFICIENCY — NOT_YET_RECRUITING · PHASE1
• Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders — SUSPENDED · PHASE1
• A Single-Centre Pilot Study Exploring the Utility of Magnetic Resonance Imaging in Patients With Chronic Lung Disease — COMPLETED · NA
• Evaluating the Use of Thromboelastography (TEG) in Patient's Requiring Extracorporeal Membrane Oxygenation (ECMO) — TERMINATED · NA
• NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease — WITHDRAWN · PHASE1
• 129 Xenon MRI in Chronic Lung Disease — OTHER · NA
• Spirometry Interpretation Performance of Primary Care Clinicians With/Without AI Software — OTHER · NA
• Comparing Methods for Tracking Health Information at Home After Lung Transplant — COMPLETED · NA
• A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC — OTHER · PHASE2
• Biomarker for Pompe Disease (BioPompe) — WITHDRAWN
• Sensing Using Neutrophil Activation Probe on the Intensive Therapy Unit — COMPLETED · PHASE2
• A DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL EVALUATING THE EFFICACY AND SAFETY OF BI 1015550 OVER AT LEAST 52 WEEKS IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES (PF-ILDS) — COMPLETED
• Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease — COMPLETED
• Regional Lung Imaging Using Hyperpolarized Xenon Gas — COMPLETED · PHASE1
• AN OPEN-LABEL TRIAL OF THE LONG-TERM SAFETY AND TOLERABILITY OF NINTEDANIB PER OS, ON TOP OF STANDARD OF CARE, OVER AT LEAST 3 YEARS, IN CHILDREN AND ADOLESCENTS WITH CLINICALLY SIGNIFICANT FIBROSING INTERSTITIAL LUNG DISEASE — COMPLETED
• Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies — COMPLETED · PHASE3
• Orkambi Exercise Study — COMPLETED
• Tomosynthesis of Pathologies of the Chest and Skeletal Structures in Comparison to CT — TERMINATED
• Development of a multiparametric MRI protocol for Evaluation of morphology, ventilation and perfusion of the lung without contrast media. — NOT_YET_RECRUITING
• PET Assessment of Acute Lung Transplant Rejection — TERMINATED
• Effects of Electronic Cigarettes on Lung Biology — TERMINATED · NA
• Respiratory Virus Infections in Acutely Hospitalized Adult Patients With Pulmonary and Extrapulmonary Complications — OTHER
• Self- management of patients with PleurX™-drainage - Experience and coping behavior of family members — OTHER
• Effect of Smoking on Ventilation-Perfusion Ratio — OTHER · NA
• Evaluation of Sleep Mode Within the Respironics SimplyGo Portable Oxygen Concentrator — COMPLETED · NA
• Natrecor in Pulmonary Hypertension — TERMINATED · PHASE4
• PHASE 2A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED PARALLEL GROUP STUDY TO INVESTIGATE THE EFFECT OF THE HYPOXIA-INDUCIBLE FACTOR (HIF) PROLYL-4-HYDROXYLASE (PHD) INHIBITOR, DAPRODUSTAT ON EXERCISE PERFORMANCE IN PATIENTS WITH CHRONIC LUNG DISEASE AND ANAEMIA — NOT_YET_RECRUITING · PHASE2
• Effects of Endotoxin in Normal Human Volunteers — COMPLETED · PHASE1
• Nondependent Lung Ventilation and Fluid Responsiveness — OTHER · PHASE3
• Study of Biologic Materials From the Mediastinal Lymph Nodes From Patients With Lung Disease. — TERMINATED
• Susceptibility to Infections in Ataxia Telangiectasia — COMPLETED · NA
• Fetal Tracheal Balloon Study in Diaphragmatic Hernia — TERMINATED · PHASE2
• Pulmonary Complications of Hematopoietic Stem Cell Transplantation — COMPLETED
• Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients — WITHDRAWN · NA
• Swimming Pool Environment Impact on the Human Respiratory Health — OTHER
• Minimally Invasive Endoscopy in Diffuse Lung Disease — COMPLETED · NA

Refine this search